NexGel, Inc. (NXGL)
0.174
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
0.1664
-0.01
(-4.37%)
After-Hours: 20:00
NexGel Enterprise Value : 7.957M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 7.957M |
| October 01, 2026 | 8.000M |
| September 30, 2026 | 7.945M |
| September 29, 2026 | 7.976M |
| September 28, 2026 | 7.996M |
| September 25, 2026 | 7.957M |
| September 24, 2026 | 8.810M |
| September 23, 2026 | 8.870M |
| September 22, 2026 | 8.935M |
| September 21, 2026 | 8.838M |
| September 18, 2026 | 8.847M |
| September 17, 2026 | 8.781M |
| September 16, 2026 | 8.676M |
| September 15, 2026 | 8.996M |
| September 14, 2026 | 8.992M |
| September 11, 2026 | 9.093M |
| September 10, 2026 | 9.083M |
| September 09, 2026 | 9.165M |
| September 08, 2026 | 9.153M |
| September 04, 2026 | 9.339M |
| September 03, 2026 | 9.561M |
| September 02, 2026 | 9.639M |
| September 01, 2026 | 9.742M |
| August 31, 2026 | 9.749M |
| August 28, 2026 | 9.683M |
| Date | Value |
|---|---|
| August 27, 2026 | 9.663M |
| August 26, 2026 | 9.722M |
| August 25, 2026 | 9.722M |
| August 24, 2026 | 9.955M |
| August 21, 2026 | 9.47M |
| August 20, 2026 | 10.03M |
| August 19, 2026 | 10.19M |
| August 18, 2026 | 9.999M |
| August 17, 2026 | 9.911M |
| August 14, 2026 | 11.75M |
| August 13, 2026 | 11.01M |
| August 12, 2026 | 10.25M |
| August 11, 2026 | 10.40M |
| August 10, 2026 | 9.784M |
| August 07, 2026 | 9.955M |
| August 06, 2026 | 9.557M |
| August 05, 2026 | 10.26M |
| August 04, 2026 | 10.35M |
| August 03, 2026 | 10.37M |
| July 31, 2026 | 10.30M |
| July 30, 2026 | 10.57M |
| July 29, 2026 | 10.60M |
| July 28, 2026 | 10.54M |
| July 27, 2026 | 10.50M |
| July 24, 2026 | 10.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IDEXX Laboratories, Inc. | 41.79B |
| Neogen Corp. | 3.272B |
| QuidelOrtho Corp. | 3.688B |
| Aspira Women's Health, Inc. | 13.72M |
| Biomerica, Inc. | 7.919M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.606M |
| Revenue (Quarterly) | 3.686M |
| Total Expenses (Quarterly) | 7.321M |
| EPS Diluted (Quarterly) | -0.4033 |
| Gross Profit Margin (Quarterly) | 30.09% |
| Profit Margin (Quarterly) | -97.83% |
| Earnings Yield | -412.2% |
| Normalized Earnings Yield | -458.22 |